Moringa

Sinopsis

Moringa (Moringa oleifera Lam.)

1. Identity

Botanical and Chemical Names

Moringa oleifera is a short-lived, fast-growing, drought-resistant tree of the family Moringaceae, native to northern India and used extensively in South and Southeast Asia. Its accepted scientific name is Moringa oleifera Lam., where "Lam." designates the botanist Jean-Baptiste Lamarck who formally described the species. A widely encountered synonym is Moringa pterygosperma Gaertn. The plant is commonly known as the "Miracle Tree," "Horseradish-tree," or "Ben oil tree."

Common names include moringa, drumstick tree (from the long, slender, triangular seed-pods), horseradish tree (from the taste of the roots, which resembles horseradish), ben tree (for its oil), or malunggay (as known in maritime or archipelagic areas in Asia).

The Moringa family comprises 13 species (M. oleifera, M. arborea, M. rivae, M. ruspoliana, M. drouhardii, M. hildebrandtii, M. concanensis, M. borziana, M. longituba, M. pygmaea, M. ovalifolia, M. peregrina, M. stenopetala), of which M. oleifera has become well known for its use in nutrition, biogas production, and fertilizer.

Morphology and Geography

Moringa oleifera grows to a height of up to 12 m, with pinnate leaves, flowers in panicles, zygomorphic, pentamerous, bisexual, and capsule-type fruits with three-winged oily seeds. It produces pendulous pods that are about 20–60 cm long and resemble those of long beans. The tree thrives globally in almost all tropical and subtropical regions, but it is believed to be native to Afghanistan, Bangladesh, India, and Pakistan.

Common Preparations and Forms

Almost all parts of the Moringa oleifera plant have potential bioactivity. Parts used include the leaves, seeds, pods, roots, bark, flowers, and gum. Moringa leaves are used to prepare dishes in Ghana, Nigeria, Ethiopia, East Africa, and Malawi. Leaves can be used fresh or as dry powder. Fresh leaves are often used in the same way as spinach or to prepare salads, sauces, and soups. Dried leaves are often milled and could be used to confer a spicy taste to dishes, also combined with other ingredients. In Western countries, the dried leaves are sold as dietary supplements, either in powder or capsule form.

2. Traditional and Historical Use

South Asian / Ayurvedic Tradition

Moringa oleifera is a plant that is native to the Indian subcontinent and has been used in traditional medicine for thousands of years owing to its nutritional and therapeutic properties. Commonly known as the drumstick plant, it has been used since ancient times for medicinal purposes, and in Ayurveda it is known as "Shigru," with many therapeutic properties described in classical texts. Its use in Ayurvedic treatment is traceable to the times of the physician Sushruta. Many parts — including the leaves, fruit, and oil — are referenced across systems related to the digestive, cardiovascular, and circulatory systems. The Ayurvedic Pharmacopoeia of India indicated the use of the dried root bark in goitre, glycosuria, and lipid disorders (also dried seeds), and leaves, seed, root bark, and stem bark in internal abscess, piles, and fistula.

An ancient culture as early as 150 B.C. incorporated moringa into their diets for benefits including healthy skin and mental alertness.

African Traditions

In African communities, the plant is locally used as food and medicine for various ailments, including diabetes, high blood pressure, ulcers, stomach aches, and body pains. All parts of the plant, including the roots, leaves, seeds, bark, gum, and flowers, are used to treat ailments like hypertension, diabetes, stomach pains, and arthritis. Moringa oleifera was introduced in Kenya by Indians at the beginning of the 20th century and is currently grown in drylands of the coastal region, Baringo, and lower eastern areas.

Broader Historical Dissemination

Moringa's popularity expanded significantly in the 20th century when researchers in the Philippines and India began studying it to combat malnutrition. Over time, usage shifted from exclusively medicinal or nutritional to modern dietary supplements and cosmetics. Flowers are either cooked or fried and may be combined with relishes. In the Philippines, the plant is known as malunggay and remains a core culinary and folk-medicinal ingredient. In Sri Lanka, the pods are cooked as a curry staple.

3. Nutritional Composition

The leaf, in particular, is recognized as one of the most nutritionally dense parts of the plant. Nutritional analysis shows that moringa leaf powder contains approximately 28.50% carbohydrates, 25.02% proteins, 10.42% fat, 11.83% dietary fiber, 1.108 mg β-carotene per 100 g, 326.4 µg/100 g vitamin B1, and 15.2 mg/100 g vitamin C.

Moringa oleifera leaves contain high levels of micronutrients: copper (0.36 ± 0.04 mg/100 g), manganese (5.80 ± 0.68 mg/100 g), iron (20.96 ± 1.37 mg/100 g), zinc (6.79 ± 1.82 mg/100 g), and β-carotene (21.42 ± 1.67 mg/100 g).

Moringa oleifera is also a good source of protein and contains 16–19 amino acids, ten of which are essential. In Moringa oleifera seeds, researchers reported 7 essential and 10 non-essential amino acids, with glutamic acid having the highest value (22.71 g/100 g protein), followed by arginine (15.78 g/100 g protein).

The main fatty acid in seed oil is oleic acid (76.78%), while leaf lipids contain oleic (25.01%), palmitic (24.84%), and linolenic (24.71%) acids. Key phenolic compounds identified include neohesperidin (126.8 mg/kg), chlorogenic acid (99.96 mg/kg), and quercetin.

Moringa leaves may also contain antinutrients such as oxalate and phytate, which can reduce the absorption of minerals and protein. This is an important consideration when interpreting nutritional content studies, as gross composition figures may overestimate bioavailable nutrient delivery.

4. Key Phytochemical Constituents and Mechanisms of Action

Primary Phytochemical Classes

So far, more than one hundred compounds from different parts of Moringa oleifera have been characterized, including alkaloids, flavonoids, anthraquinones, vitamins, glycosides, and terpenes. The high nutritional, nutraceutical, and therapeutic profile is mainly attributed to its rich repertoire of biologically active molecules: proteins (peptides and protein hydrolysates), flavonoids, saponins, phenolic acids, tannins, isothiocyanates, lipids, minerals, and vitamins, amongst others.

Flavonoids: Key flavonoids include quercetin, kaempferol, ascorbic acid, flavonoids, and phenolic acids, which underlie many of the plant's antioxidant, anti-inflammatory, and anti-apoptotic properties.
Glucosinolates and Isothiocyanates: Glucosinolate compounds isolated from ethanol extracts of seeds include 4-(α-L-rhamnopyranosyloxy)-benzylglucosinolate, moringaside C through G, moringin (26), niazimicin (27), and glucomoringin (28). The leaves, which contain benzyl isothiocyanate, glucosinolates, and niazimicin, are believed to be responsible for the plant's anticancer activity.
Phenolic acids: Other phenolic compounds that can be isolated from various parts of M. oleifera include caffeic acid, gallic acid, p-coumaric acid, and vanillin.
Novel alkaloids: Novel isolates such as muramoside A&B and niazimin A&B have been identified and possess potent antioxidant, anticancer, antihypertensive, hepatoprotective, and nutritional effects.
Carotenoids: β-carotene is present in significant quantities and serves as a provitamin A precursor. It is worth highlighting the total carotenoid content (1.10 mg β-carotene) found in leaf powder.
Sterols: Gamma-sitosterol (3.83%) and palmitoleamide (4.1%) were identified as notable constituents, alongside squalene, stigmasterol, trans-resveratrol, and phytol.

Anti-Inflammatory Mechanisms

The compounds of M. oleifera are thought to exert anti-inflammatory effects through: (1) inhibition of pro-inflammatory enzymes — quercetin and kaempferol inhibit cyclooxygenase (COX) and lipoxygenase (LOX); (2) regulation of cytokine production — isothiocyanates modulate the NF-κB pathway and inhibit production of pro-inflammatory cytokines such as TNF-α and IL-1β. β-Sitosterol, a phytosterol from moringa, has the ability to suppress production of inflammatory factors including TNF-α, IL-1β, IL-6, IL-8, NFκB, and reactive oxygen species (ROS).

Antioxidant Mechanisms

The anti-inflammatory nature of M. oleifera is partly attributed to the abundance of quercetin, which has the capability to inhibit NF-κB activity — a key driver of the inflammatory response. Key phytoconstituents help to maintain brain antioxidant enzyme levels, mitochondrial functions, and neurogenesis, showing neuroprotective effects in several neurodegenerative disorders including Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, and amyotrophic lateral sclerosis.

Antihyperlipidemic Mechanisms

The antihyperlipidemic activity of Moringa oleifera is reported to be due to phytochemicals such as flavonoids, phytosterols, and phenols.

5. Scientific Evidence by Area of Use

5.1 Glycemic Control and Diabetes

Evidence summary: Several human clinical trials have examined moringa's effect on blood glucose, and the totality of evidence is encouraging but limited by methodological constraints.

Water and organic solvent extracts of leaves and, secondarily, seeds have been extensively assayed in animal models, showing a hypoglycemic effect both under acute conditions and in long-term administrations, and also prevention of metabolic changes and complications associated with hyperglycemic status.

In humans, clinical trials are scarce, with variable designs, testing mainly dry leaf powder alone or mixed with other foods or aqueous preparations. Although the reported results are encouraging — especially those from postprandial studies — more human studies are certainly needed with more stringent inclusion criteria and a sufficient number of diabetic or prediabetic subjects.

One randomized controlled trial (RCT) in a rural Nigerian community adopted a parallel-group design. Forty adult male and female diabetic subjects were randomly assigned to four groups — a control group fed diets without moringa leaves, and experimental groups receiving 20 g, 40 g, and 60 g of Moringa leaves respectively, daily for 14 days.

In a randomized controlled trial in Spain, moringa consumed as six daily capsules of dry leaf powder (2.4 g/day) for 12 weeks significantly decreased fasting blood glucose and glycated hemoglobin (HbA1c) among prediabetic subjects.

The meta-analytic evidence on glycemia is mixed. Subgroup analysis in one earlier meta-analysis showed that moringa powder significantly decreased fasting blood sugar and total cholesterol, and that moringa treatment for more than 30 days could significantly decrease fasting blood sugar. However, a more rigorous 2025 meta-analysis of nine RCTs (12 study arms) involving 341 participants in intervention and 308 in control groups found that moringa supplementation showed no significant effects on most considered cardiometabolic outcomes. The authors concluded that current evidence does not support consistent cardiometabolic benefits of moringa supplementation in adults, and that large-scale, rigorously designed RCTs are warranted to clarify its therapeutic potential and optimal supplementation parameters.

5.2 Lipid Profile and Cardiovascular Risk

Evidence summary: Mixed results from small RCTs; a recent 2025 meta-analysis found no significant overall effect on lipid parameters in the pooled data.

Earlier meta-analytic work suggested potential effects on LDL and total cholesterol, but results were attributed to the included studies being performed in normocholesterolemic and borderline hyperlipidemia participants with short study durations (less than 3 months).

A recent clinical synthesis noted that a high-quality 2025 meta-analysis of 12 RCTs (n=1,054) demonstrated significant improvements in blood pressure, LDL-cholesterol, and glycemic parameters with a clear dose-response relationship and good safety profile. However, this conflicts with the findings of the GRADE-assessed 2025 analysis cited above, which found no significant pooled effects, illustrating the contested state of the evidence.

5.3 Blood Pressure / Antihypertensive Effects

Evidence summary: Preliminary evidence from preclinical studies; human RCT evidence is insufficient to draw firm conclusions.

Many preclinical studies attribute antihypertensive properties to M. oleifera, particularly the leaves. However, it is premature to draw firm conclusions, as there is a great lack of randomized controlled trials demonstrating its real efficacy, and the mechanisms of action and the compounds responsible for the hypotensive effect have not yet been fully elucidated.

Subgroup analyses from one 2025 meta-analysis showed that diastolic blood pressure (DBP) decreased significantly in trials lasting ≥12 weeks and when participants received <10 g/day of moringa, while systolic blood pressure (SBP) did not decrease significantly in subgroup analyses.

Further clinical trials showing efficacy are strongly required before promoting moringa for therapeutic purposes. At present, moringa remains a plant with nutritional and pharmacological potential in this domain.

5.4 Anti-Inflammatory Effects

Evidence summary: Mechanistic evidence is robust in vitro and in animal models; human clinical evidence remains preliminary.

The major anti-inflammatory mechanism reported for M. oleifera is the inhibition of the NF-κB pathway. Multiple fractions of moringa leaf (hexane, chloroform, ethyl acetate, and butanol) have been shown to reduce IL-1β, IL-6, PGE2, TNF-α, and nitric oxide production in LPS-stimulated macrophages. These remain primarily preclinical observations.

A clinical trial involving subjects with mild to moderate asthma demonstrated a significant increase in Forced Vital Capacity (FVC), forced expiratory volume (FEV), and peak expiratory flow rate (PEFR) following the consumption of Moringa oleifera dry seed powder without adverse effects. This represents one of the few human studies bearing on respiratory/inflammatory outcomes, though sample sizes were small.

5.5 Antioxidant Effects

Evidence summary: Strong in vitro antioxidant activity demonstrated; human evidence is limited.

Leaf extracts exhibit the greatest antioxidant activity, and various safety studies in animals involving aqueous leaf extracts indicate a high degree of safety. Total phenols in powdered leaves' extract (635.6 mg GAE/L) are higher than in powdered seeds' extract (229.5 mg GAE/L). The activity against superoxide radical and hydroxyl radical was 92.4% and 73.1% by leaves' powder extract and 83.6% and 60.7% by crushed-leaf extract.

5.6 Neuroprotective Effects

Evidence summary: Preclinical and in vitro data only; no adequate human clinical trials identified.

In developing countries, moringa is used as feed for both humans and animals due to its well-known antioxidant, anti-inflammatory, and anti-apoptotic properties. Its phytoconstituents — including β-carotene, quercetin, kaempferol, ascorbic acid, flavonoids, phenolic acid, rhamnose, glycosylates, glucomoringin, and isothiocyanates — help to maintain brain antioxidant enzyme levels, mitochondrial functions, and neurogenesis, showing neuroprotective effects in several neurodegenerative disorders including Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, and ALS in preclinical models.

Research in animal models found that quercetin acts against neuronal cell death through the activation of Nrf2 and reduction of D-galactose-induced cognitive impairment. It increased Nrf2-targeted antioxidant enzymes HO-1 and SOD. In an LPS-induced oxidative stress study, quercetin suppressed intracellular ROS formation and inhibited NF-κB nuclear translocation, reducing levels of inflammatory factors. These findings are preclinical and have not yet been replicated in registered human trials.

5.7 Antimicrobial Activity

Evidence summary: In vitro activity demonstrated; no significant human clinical trials identified.

This plant is reported to be active in vitro to inhibit several oral bacteria such as E. faecalis, S. mutans, P. gingivalis, S. aureus, and C. albicans, and has been tested ex vivo. Translating these findings to clinical utility requires human study data that are not currently available.

5.8 Malnutrition and Nutritional Supplementation

Evidence summary: One of the better-supported applications, with documented real-world use and program data from international development organizations.

M. oleifera leaf powder contains high levels of the micronutrients β-carotene, zinc, manganese, and iron, comparable to levels found in amaranth and spinach. Leaf-fortified local dishes were well accepted by children in a Ghanaian study, and moringa leaf-fortified dishes could be good sources of β-carotene and other minerals for children vulnerable to malnutrition.

Moringa oleifera leaf contains high protein and mineral contents and low content of lipids, and can be incorporated into the diet as a functional ingredient or fortifier.

6. Dosage Forms and Reported Doses in Studies

Moringa is available as:

Dried leaf powder — used in both food fortification and encapsulated supplement form.
Capsules/tablets — containing standardized or unstandardized leaf powder.
Aqueous extracts and teas — prepared by infusion of leaves.
Seed powder — used separately, e.g., in one asthma study.
Fresh leaves — consumed directly or cooked.
Seed oil (ben oil) — used topically and as a food oil.

Doses reported in specific human studies:

Experimental groups in a Nigerian RCT received 20 g, 40 g, and 60 g of moringa leaves respectively daily for 14 days in addition to their diets.
In a Spanish RCT, moringa was consumed as six daily capsules of dry leaf powder (2.4 g/day) for 12 weeks.
In a pharmacokinetic interaction study, participants received 1.85 g of moringa leaf powder per day during co-administration with nevirapine.
Among studies conducted with human subjects with diabetes, no adverse effects were reported with whole leaf powder at up to a single dose of 50 g or using an 8 g per day dose for 40 days.
Subgroup analysis from a 2025 meta-analysis found effects on diastolic blood pressure in trials where participants received less than 10 g/day of moringa.

No universally established or pharmacopeial standardized dose exists for moringa as a therapeutic agent.

7. Safety Considerations and Drug Interactions

General Tolerability

Leaf extracts exhibit the greatest antioxidant activity, and various safety studies in animals involving aqueous leaf extracts indicate a high degree of safety. No adverse effects were reported in association with human studies reviewed in the published safety and efficacy literature through 2015.

The potential toxicological effects of a single oral dose of 5000 mg/kg of an aqueous moringa extract, as well as oral doses of up to 1000 mg/kg for 14 days on rats, were examined — the authors noted that no overt adverse reactions were observed at these doses and no histopathological findings were found.

Hepatotoxicity

In small clinical trials, moringa preparations have not been implicated in causing serum enzyme or bilirubin elevations. Until recently there were no published reports of clinically apparent liver injury attributed to moringa extracts. In multiple large registries and case series of drug- and dietary supplement-induced liver injury, moringa was not listed as an implicated agent — until a recent case series from South America reported a single case attributed to Moringa oleifera from Brazil. Moringa is widely used as a food supplement and appears to be well tolerated, such that liver injury from its use must be very rare. The NIH LiverTox database assigns it a Likelihood Score of D (possible rare cause of clinically apparent liver injury).

Rare Adverse Events

The clinical significance of rare case reports of severe adverse drug reactions (ADRs), such as Stevens–Johnson syndrome, should not be ignored, pointing to the need for thorough monitoring and careful care of patients, particularly elderly or vulnerable patients. However, methodological variability and extract standardization remain key obstacles that prevent its formal recognition as a clinically validated phytomedicine.

Cytochrome P450 Interactions

Moringa oleifera, an herb commonly consumed by HIV-infected people on antiretroviral therapy, inhibits cytochrome P450 3A4, 1A2, and 2D6 activity in vitro, and may alter the pharmacokinetics of antiretroviral drugs metabolized via the same pathways. However, in vitro drug interaction activity may not translate to a clinically significant effect. Therefore, the effect of moringa leaf powder on the pharmacokinetics of nevirapine in HIV-infected people was investigated. The results of that clinical study are published but the in vitro CYP inhibition signal flags a theoretical interaction with any drugs that are substrates of CYP3A4, CYP1A2, or CYP2D6.

Blood Pressure Drug Interactions

Given the documented — though mechanistically unresolved — antihypertensive effects of moringa leaves, co-administration with antihypertensive pharmaceutical agents may theoretically cause additive blood pressure reduction. It is premature to draw firm conclusions about real efficacy, as there is a great lack of randomized controlled trials.

Antinutrients

Moringa leaves may contain high levels of antinutrients, such as oxalate and phytate, which can reduce the absorption of minerals and protein. This is relevant particularly in populations relying on moringa as a primary dietary micronutrient source.

Standardization Gap

Future research should focus on conducting large-scale, multicenter RCTs using standardized extracts with defined phytochemical profiles. Performing pharmacokinetic and pharmacodynamic studies to clarify absorption, metabolism, and drug–herb interactions has also been recommended. Implementing long-term safety and pharmacovigilance frameworks to monitor rare adverse events will be critical for vulnerable patients.

8. Body Systems and Health Areas Associated with Moringa

Endocrine/Metabolic: Glycemic regulation, antidiabetic effects, lipid modulation (clinical evidence limited and mixed).
Cardiovascular: Blood pressure regulation, antihyperlipidemic effects (primarily preclinical; human data inconclusive).
Immune/Inflammatory: NF-κB inhibition, cytokine modulation, antioxidant activity (robust preclinical; limited clinical).
Neurological: Neuroprotection via Nrf2/HO-1 and NF-κB pathways (preclinical only).
Nutritional/Hematologic: Iron, protein, zinc, and β-carotene supply; potential in malnutrition management (practical evidence).
Antimicrobial/Dental: Active in vitro against oral bacteria including E. faecalis, S. mutans, P. gingivalis, S. aureus, and C. albicans. No clinical evidence.
Respiratory: One clinical trial involving subjects with mild to moderate asthma demonstrated a significant increase in Forced Vital Capacity, forced expiratory volume, and peak expiratory flow rate following consumption of moringa dry seed powder.
Hepatic: Hepatoprotective effects suggested in animal models; pharmacological studies confirm the hepatoprotective potential of extracts from various plant parts.

9. Overall Evidence Assessment

Moringa oleifera is a botanically and nutritionally well-characterized plant with a rich history of traditional use across multiple continents. Its phytochemical complexity — encompassing flavonoids, isothiocyanates, glucosinolates, phenolic acids, carotenoids, and a complete amino acid profile — provides a plausible mechanistic basis for many of its attributed effects. However, methodological variability and extract standardization remain key obstacles that prevent its formal recognition as clinically validated phytomedicine. The most recent and rigorous meta-analytic evidence, published in 2025, concludes that current evidence does not support consistent cardiometabolic benefits of moringa supplementation in adults, and that large-scale, rigorously designed RCTs are warranted to clarify its therapeutic potential and optimal supplementation parameters. Its best-evidenced application at this time remains in nutritional supplementation for micronutrient-deficient populations.

References

Condiciones de Salud

Condiciones de salud que Moringa puede ayudar a apoyar.

DispepsiaCientífico
Moringa oleifera leaves provide approximately 28 mg iron per 100 g dried powder, along with vitamin C and beta-carotene that enhance iron bioavailability. Multiple clinical studies in anemic adolescent girls and postpartum women demonstrate significant hemoglobin improvements with supplementation. Also used in Ayurveda as 'Shigru' for anemia.
AlcoholismoCientífico
Moringa oleifera leaf is a well-researched natural galactagogue used extensively in the Philippines (malunggay) and across Asia. A 2025 systematic review of 8 RCTs found Moringa supplementation significantly increased breast milk volume by up to 400 mL/day and raised serum prolactin by a mean of 231.72 ng/mL compared to controls. A 2026 Bayesian meta-analysis of 14 studies (865 subjects) confirmed a large, clinically meaningful effect size. NIH LactMed cites Moringa as safe with no reported adverse effects in nursing mothers.
CarbúnculosCientífico
Moringa oleifera leaf powder is exceptionally rich in iron (~28 mg/100g dry weight) and vitamin C, and has emerging clinical trial evidence for supporting iron status in iron-deficient populations, particularly pregnant women. An ongoing RCT (NCT06875947) specifically evaluates its effects on hematological profiles in IDA.
Daño del CartílagoCientífico
Moringa oleifera has preclinical evidence for nephroprotective effects, demonstrating the ability to reduce kidney damage markers and oxidative stress in animal models. Rich in antioxidant flavonoids (quercetin, myricetin), kaempferol, and glucosinolates, it has been studied for protection against nephrotoxin-induced and diabetes-related kidney injury. In Ayurveda it is prescribed for kidney stone management and urinary health.
ConvalecenciaCientífico
Moringa (Moringa oleifera) is one of the most evidence-supported herbal galactagogues for postpartum use. A meta-analysis of 14 studies (865 subjects) found Moringa increases serum prolactin, milk volume, and milk quality. NIH LactMed and a 2025 systematic review (PRISMA guidelines) confirm its efficacy for postpartum lactation insufficiency.
ConjuntivitisTradicional
Moringa oleifera (drumstick tree) is used in Ayurvedic, African, and Southeast Asian traditional medicine as a nutritional tonic for debility, convalescence, and malnutrition recovery. Its leaves contain exceptionally high concentrations of vitamins (C, A, B-complex), minerals, and all essential amino acids supporting post-illness nutritional rehabilitation.